Jean-Claude Desenclos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jean-Claude Desenclos has a total of 173 co-authors. Here are the top co-authors by number of shared publications:
- Henriette de Valk
Infectious Diseases Department, Institut de Veille Sanitaire, 12 rue du val d'osne, 94415, Saint Maurice, France
5 shared publications V Vaillant
3 shared publicationsA Infuso
European Programme for Intervention Epidemiology Training (EPIET), CHU Bichat Claude Bernard, Paris
2 shared publicationsB Hubert
Réseau National de Santé Publique, St Maurice
2 shared publicationsC. Meffre
2 shared publicationsCaroline Semaille
Institut de veille sanitaire (InVS), Département des maladies infectieuses (DMI), Saint-Maurice, France
2 shared publications
Latest Publications
- 1 May 2013
- Vol. 17 (3) , 132-144
Epidemiology of HIV in the world: particularities of epidemics in the North and South
Thirty years after the identification of the first cases of AIDS, it was estimated that 34 million of people were living with HIV worldwide in 2011. The incidence is declining but remains high, with 2.5 million of new HIV infections per year. Africa is the region of the world most heavily affected, accounting for three-quarters of the global burden of HIV infection and the same proportion for new infections. The incidence declines in most parts of the world while heterosexual transmission remains the dominant mode of HIV acquisition followed by homosexual transmission. Intravenous drug use continues to drive the epidemic in Eastern Europe and parts of Asia. Condom use remains the cornerstone of prevention of sexual transmission. Male medical circumcision has now been proven an effective public health intervention to prevent sexual transmission. Antiretroviral treatment may reduce sexual transmission at population level while improving the conditions of life and survival of those harbouring the virus. Harm-reduction together with blood safety prevent blood transmission. The prevention of mother-to-child transmission is now moving its global objective to elimination by the end of 2015. At least 20 years will be necessary for achieving HIV control at the worldwide level with currently available interventions.
- 1 May 2013
- Vol. 17 (3) , 132-144
Epidemiology of HIV in the world: particularities of epidemics in the North and South
Thirty years after the identification of the first cases of AIDS, it was estimated that 34 million of people were living with HIV worldwide in 2011. The incidence is declining but remains high, with 2.5 million of new HIV infections per year. Africa is the region of the world most heavily affected, accounting for three-quarters of the global burden of HIV infection and the same proportion for new infections. The incidence declines in most parts of the world while heterosexual transmission remains the dominant mode of HIV acquisition followed by homosexual transmission. Intravenous drug use continues to drive the epidemic in Eastern Europe and parts of Asia. Condom use remains the cornerstone of prevention of sexual transmission. Male medical circumcision has now been proven an effective public health intervention to prevent sexual transmission. Antiretroviral treatment may reduce sexual transmission at population level while improving the conditions of life and survival of those harbouring the virus. Harm-reduction together with blood safety prevent blood transmission. The prevention of mother-to-child transmission is now moving its global objective to elimination by the end of 2015. At least 20 years will be necessary for achieving HIV control at the worldwide level with currently available interventions.
- Open Access
- 28 June 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 488
Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial
In France, the rapid scale-up of buprenorphine, an opioid maintenance treatment (OMT), in primary care for drug users has led to an impressive reduction in HIV prevalence among injecting drug users (IDU) but has had no major effect on Hepatitis C incidence. To date, patients willing to start methadone can only do so in a methadone clinic (a medical centre for drug and alcohol dependence (CSAPA) or a hospital setting) and are referred to primary care physicians after dose stabilization. This study aims to assess the effectiveness of methadone in patients who initiated treatment in primary care compared with those who initiated it in a CSAPA, by measuring abstinence from street opioid use after one year of treatment.
- 28 June 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 488
Open AccessMethadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial
In France, the rapid scale-up of buprenorphine, an opioid maintenance treatment (OMT), in primary care for drug users has led to an impressive reduction in HIV prevalence among injecting drug users (IDU) but has had no major effect on Hepatitis C incidence. To date, patients willing to start methadone can only do so in a methadone clinic (a medical centre for drug and alcohol dependence (CSAPA) or a hospital setting) and are referred to primary care physicians after dose stabilization. This study aims to assess the effectiveness of methadone in patients who initiated treatment in primary care compared with those who initiated it in a CSAPA, by measuring abstinence from street opioid use after one year of treatment.
- Open Access
- 8 June 2012
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 12 (1) , 73
Practical considerations for sensitivity analysis after multiple imputation applied to epidemiological studies with incomplete data
Multiple Imputation as usually implemented assumes that data are Missing At Random (MAR), meaning that the underlying missing data mechanism, given the observed data, is independent of the unobserved data. To explore the sensitivity of the inferences to departures from the MAR assumption, we applied the method proposed by Carpenter et al. (2007).
- 8 June 2012
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 12 (1) , 73
Open AccessPractical considerations for sensitivity analysis after multiple imputation applied to epidemiological studies with incomplete data
Multiple Imputation as usually implemented assumes that data are Missing At Random (MAR), meaning that the underlying missing data mechanism, given the observed data, is independent of the unobserved data. To explore the sensitivity of the inferences to departures from the MAR assumption, we applied the method proposed by Carpenter et al. (2007).
- 1 November 2011
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 41 (11) , 588-593
Transmission parameters of vector-borne infections
- 1 November 2011
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 41 (11) , 588-593
Transmission parameters of vector-borne infections
- 31 March 2011
- Published by Elsevier in Journal of Hepatology
- Vol. 54, S539-S540
1362 THE AVAILABILITY OF DIRECT ACTING ANTIVIRALS (DAA) IN 2012: A FRENCH MODEL-BASED ANALYSIS OF THE INCREASED NUMBER OF PATIENTS TREATED FOR CHRONIC HCV INFECTION
- 31 March 2011
- Published by Elsevier in Journal of Hepatology
- Vol. 54, S539-S540
1362 THE AVAILABILITY OF DIRECT ACTING ANTIVIRALS (DAA) IN 2012: A FRENCH MODEL-BASED ANALYSIS OF THE INCREASED NUMBER OF PATIENTS TREATED FOR CHRONIC HCV INFECTION
- 19 November 2009
- Vol. 14 (46)
RAISIN - a national programme for early warning, investigation and surveillance of healthcare-associated infection in France.
Surveillance is a key component of the French plan for prevention of healthcare-associated infection (HAI) and has progressively evolved in the past decades. We describe the development and current organisation of surveillance of HAI in France and summarise key achievements and results. Surveillance of HAI is under the auspice of the national institute for public health surveillance through a central coordinating structure, the Reseau d alerte, d investigation et de surveillance des infections nosocomiales (RAISIN), which consists of five regional coordinating structures, two national advisory committees of the Ministry of Health and public health agencies. Surveillance includes the performance of national prevalence surveys every five years (latest in 2006), specific surveillance networks to follow trends and characterise HAI that are national priority, and mandatory reporting of HAI that meet specific criteria for alert purposes. RAISIN prioritises activities, defines technical specifications of surveillance systems, coordinates their implementation, and supports response to alerts, emergences or outbreaks of HAI. We demonstrate that the French surveillance program of HAI has become comprehensive and contributes to evaluating the impact of control and prevention of HAI. Data from RAISIN indicate a general decrease in the risk of HAI in acute care in France. They show a decrease in HAI during recent years, particularly of those related to methicillin-resistant Staphylococcus aureus (MRSA) for which a drop of 38% was documented between 2001 and 2006. RAISIN is also integrated into European surveillance of HAI coordinated by the European Centre for Disease Control.
- 19 November 2009
- Vol. 14 (46)
RAISIN - a national programme for early warning, investigation and surveillance of healthcare-associated infection in France.
Surveillance is a key component of the French plan for prevention of healthcare-associated infection (HAI) and has progressively evolved in the past decades. We describe the development and current organisation of surveillance of HAI in France and summarise key achievements and results. Surveillance of HAI is under the auspice of the national institute for public health surveillance through a central coordinating structure, the Reseau d alerte, d investigation et de surveillance des infections nosocomiales (RAISIN), which consists of five regional coordinating structures, two national advisory committees of the Ministry of Health and public health agencies. Surveillance includes the performance of national prevalence surveys every five years (latest in 2006), specific surveillance networks to follow trends and characterise HAI that are national priority, and mandatory reporting of HAI that meet specific criteria for alert purposes. RAISIN prioritises activities, defines technical specifications of surveillance systems, coordinates their implementation, and supports response to alerts, emergences or outbreaks of HAI. We demonstrate that the French surveillance program of HAI has become comprehensive and contributes to evaluating the impact of control and prevention of HAI. Data from RAISIN indicate a general decrease in the risk of HAI in acute care in France. They show a decrease in HAI during recent years, particularly of those related to methicillin-resistant Staphylococcus aureus (MRSA) for which a drop of 38% was documented between 2001 and 2006. RAISIN is also integrated into European surveillance of HAI coordinated by the European Centre for Disease Control.
- 1 August 2008
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 38 (8) , 449-451
La transmission aérienne des agents infectieux
- 1 August 2008
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 38 (8) , 449-451
La transmission aérienne des agents infectieux
- 1 February 2007
- Published by Elsevier in Revue Française des Laboratoires
- Vol. 2007 (389) , 49
Actualités sur l'épidémiologie des gastro-entérites virales en France en 2006
- 1 February 2007
- Published by Elsevier in Revue Française des Laboratoires
- Vol. 2007 (389) , 49
Actualités sur l'épidémiologie des gastro-entérites virales en France en 2006
- 1 February 2007
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 37 (2) , 77-94
Les principes de l'investigation d'une épidémie dans une finalité de santé publique
- 1 February 2007
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 37 (2) , 77-94
Les principes de l'investigation d'une épidémie dans une finalité de santé publique
- 31 December 2006
- Published by Elsevier in Journal of Clinical Virology
- Vol. 36, S197
P.440 Prevalence of hepatitis B and hepatitis C in France, 2004
- 31 December 2006
- Published by Elsevier in Journal of Clinical Virology
- Vol. 36, S197
P.440 Prevalence of hepatitis B and hepatitis C in France, 2004